HCPLive

Don't Forget Patient Privacy When Marketing Your Practice

MONDAY, July 7, 2014 (HealthDay News) -- Use of marketing by health care providers must be in accordance with federal and state regulations relating to patient privacy, according to an article published June 24 in Medical Economics.

Noting that many providers are considering or pursuing use of marking activities to bolster their practices, Matthew Colongeli, JD, from Garfunkel Wild, P.C., in Great Neck, NY, discusses the importance of considering patient privacy when developing marketing strategies.

According to Cologneli, health care providers need to be aware of potential violations of the Health Insurance Portability and Accountability Act (HIPAA) via use or disclosure of a patient's protected health information (PHI). In general, HIPAA authorizations must comprise information such as the specific information to be disclosed; who is authorized to use or disclose the PHI and to whom; and the purpose of the use or disclosure. In addition to HIPAA-compliant authorization, health care providers must ensure that marketing activities are in accordance with federal and state statutes and regulations. Use of patient testimonials as a marketing tool are discussed in a guide released by the Federal Trade Commission and should be in accordance with the Federal Trade Commission Act (FTCA).

"The use of marketing by healthcare providers will continue to grow and evolve," Colongeli writes. "It is essential that providers develop and implement a marketing strategy that is compliant with HIPAA, the FTCA, and all other federal and state laws."

More Information

Copyright © 2014 HealthDay. All rights reserved.

Most Popular

Recommended Reading

In a perspectives piece published in the April 2015 issue of JAMA Internal Medicine, physicians from Montefiore Medical Center in New York City underscored the importance of removing language barriers.
With the increasing number of patients turning to epidural steroid injections for pain relief, specialists with the US Food and Drug Administration (FDA) Safe Use Initiative gathered specialists to improve the procedure.
To prescribe or not to prescribe? – That is the question that practitioners face regarding antibiotics. While they can be extremely beneficial, the medication proved to be the deadly approach for one patient.
For patients with Alzheimer's Disease, as their condition worsens it often falls on other members of their family to make decisions about their course of treatment. What they are expected to do and how they make certain decisions can have long lasting impacts on the care of the people with the disease.
$vAR$